Venrock Healthcare Capital Reports a $6.4 Million KALV Purchase

January 2, 2024

From the Desk of Steve Strazza and Alfonso Depablos

The most significant transaction on today’s list comes in a Form 4 filing by Venrock Healthcare Capital Partners.

The firm reported a purchase of roughly $6.4 million in KalVista Pharmaceuticals Inc $KALV.

Here’s The Hot Corner, with data through December 29, 2023:

In another Form 4, the CEO of HighPeak Energy $HPK revealed a purchase of $2,421,955.

In the options market, there was bullish flow in Joby Aviation Inc $JOBY.

Stay tuned. We’ll be back on Wednesday with more insider activity.

Filed Under: